Teva Pharmaceutical Industries (TEVA) Short Interest Ratio & Short Volume $20.88 +4.37 (+26.47%) (As of 12/17/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Teva Pharmaceutical Industries Short Interest DataTeva Pharmaceutical Industries (TEVA) has a short interest of 22.41 million shares. This marks a 5.76% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.3, indicating that it would take 3.3 days of the average trading volume of 9.35 million shares to cover all short positions.Current Short Interest22,410,000 sharesPrevious Short Interest21,190,000 sharesChange Vs. Previous Month+5.76%Dollar Volume Sold Short$376.04 millionShort Interest Ratio3.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares1,132,909,000 sharesPercentage of Shares Shorted1.98%Today's Trading Volume57,811,334 sharesAverage Trading Volume9,350,997 sharesToday's Volume Vs. Average618% Short Selling Teva Pharmaceutical Industries? Sign up to receive the latest short interest report for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTEVA Short Interest Over TimeTEVA Days to Cover Over TimeTEVA Percentage of Float Shorted Over Time Ad Wall Street StarHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the Teva Pharmaceutical Industries Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202422,410,000 shares $376.04 million +5.8%N/A3.3 $16.78 11/15/202421,190,000 shares $348.26 million +17.1%N/A3.1 $16.44 10/31/202418,090,000 shares $333.76 million -9.1%N/A2.7 $18.45 10/15/202419,910,000 shares $361.57 million -18.7%N/A2.7 $18.16 9/30/202424,490,000 shares $441.31 million -19.3%N/A3 $18.02 9/15/202430,340,000 shares $558.56 million +26.7%N/A3.5 $18.41 Get the Latest News and Ratings for TEVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. 8/31/202423,950,000 shares $451.94 million -0.2%N/A2.7 $18.87 8/15/202423,990,000 shares $439.62 million +23.0%N/A2.7 $18.33 7/31/202419,500,000 shares $339.69 million +10.3%N/A1.9 $17.42 7/15/202417,680,000 shares $301.97 million -20.8%N/A1.8 $17.08 6/30/202422,310,000 shares $362.54 million -9.2%N/A2.2 $16.25 6/15/202424,560,000 shares $421.45 million +35.8%N/A2.5 $17.16 5/31/202418,080,000 shares $306.09 million +39.1%N/A1.9 $16.93 5/15/202413,000,000 shares $218.14 million +6.4%N/A1.3 $16.78 4/30/202412,220,000 shares $171.45 million +4.8%N/A1.3 $14.03 4/15/202411,660,000 shares $154.26 million +0.9%N/A1.1 $13.23 3/31/202411,560,000 shares $163.11 million +10.5%N/A1.1 $14.11 3/15/202410,460,000 shares $140.53 million -28.9%N/A1 $13.44 2/29/202414,720,000 shares $193.27 million -4.4%N/A1.4 $13.13 2/15/202415,390,000 shares $202.99 million -16.0%N/A1.5 $13.19 1/31/202418,320,000 shares $221.67 million +9.3%N/A1.8 $12.10 1/15/202416,760,000 shares $189.72 million +2.5%N/A1.9 $11.32 12/31/202316,350,000 shares $170.69 million +15.8%N/A1.9 $10.44 12/15/202314,120,000 shares $140.92 million +6.1%N/A1.7 $9.98 11/30/202313,310,000 shares $130.77 million -6.1%N/A1.5 $9.83 11/15/202314,180,000 shares $127.19 million -18.9%N/A1.7 $8.97 10/31/202317,490,000 shares $150.06 million +19.2%N/A2.1 $8.58 10/15/202314,670,000 shares $127.04 million +8.1%N/A1.6 $8.66 9/30/202313,570,000 shares $138.41 million -19.5%N/A1.4 $10.20 9/15/202316,850,000 shares $178.10 million -0.3%N/A1.8 $10.57 8/31/202316,900,000 shares $164.94 million -18.4%N/A1.7 $9.76 8/15/202320,710,000 shares $197.47 million -8.8%N/A1.7 $9.54 7/31/202322,710,000 shares $190.65 million +18.7%N/A1.6 $8.40 7/15/202319,130,000 shares $157.06 million +18.7%N/A1.5 $8.21 6/30/202316,120,000 shares $121.30 million -24.4%N/A1.2 $7.53 6/15/202321,330,000 shares $161.68 million +0.1%N/A1.6 $7.58 5/31/202321,300,000 shares $153.15 million +52.5%N/A1.6 $7.19 5/15/202313,970,000 shares $112.74 million +9.7%N/A1.2 $8.07 4/30/202312,730,000 shares $111.13 million -16.6%N/A1.4 $8.73 4/15/202315,260,000 shares $126.51 million -7.4%N/A1.7 $8.29Combine the QQQ, IWM and SPY in one trade (Ad)If you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here. 3/31/202316,480,000 shares $145.85 million -15.9%N/A1.8 $8.85 3/15/202319,590,000 shares $169.85 million -23.4%N/A2.2 $8.67 2/28/202325,570,000 shares $253.40 million -7.6%N/A2.9 $9.91 2/15/202327,680,000 shares $285.38 million -2.4%N/A3.1 $10.31 1/31/202328,350,000 shares $298.81 million +13.3%N/A2.9 $10.54 1/15/202325,020,000 shares $281.22 million -20.5%N/A2.6 $11.24 12/30/202231,470,000 shares $287.01 million +31.2%N/A3.3 $9.12 12/15/202223,980,000 shares $214.86 million -22.7%N/A2.6 $8.96 11/30/202231,030,000 shares $272.13 million +0.7%N/A3.4 $8.77 11/15/202230,810,000 shares $282.84 million +2.1%N/A3.3 $9.18 10/31/202230,190,000 shares $269.29 million +3.8%N/A2.9 $8.92 10/15/202229,080,000 shares $231.19 million -0.2%N/A2.3 $7.95 9/30/202229,150,000 shares $235.24 million +12.4%N/A2.2 $8.07 9/15/202225,940,000 shares $230.61 million +28.0%N/A1.9 $8.89 8/31/202220,270,000 shares $183.24 million -9.8%N/A1.4 $9.04 8/15/202222,460,000 shares $251.55 million +11.8%N/A1.6 $11.20 7/31/202220,090,000 shares $188.44 million +13.1%N/A1.5 $9.38 7/15/202217,760,000 shares $124.50 million +4.1%N/A1.7 $7.01 6/30/202217,060,000 shares $128.29 million -12.0%N/A1.7 $7.52 6/15/202219,380,000 shares $157.56 million +1.8%1.8%1.9 $8.13 5/31/202219,040,000 shares $173.26 million -7.0%N/A2.2 $9.10 5/15/202220,470,000 shares $158.85 million +21.2%N/A2.3 $7.76 4/30/202216,890,000 shares $147.11 million -7.5%N/A1.9 $8.71 4/15/202218,260,000 shares $186.07 million -12.7%N/A2.1 $10.19 3/31/202220,910,000 shares $196.34 million -3.7%N/A2.3 $9.39 3/15/202221,720,000 shares $162.90 million +5.4%N/A2.4 $7.50 2/28/202220,610,000 shares $167.56 million +12.3%N/A2.2 $8.13 2/15/202218,360,000 shares $155.33 million -16.6%N/A1.9 $8.46 1/31/202222,020,000 shares $185.63 million +4.3%N/A2.3 $8.43 1/15/202221,110,000 shares $193.58 million +14.1%N/A2 $9.17 12/31/202118,500,000 shares $148.19 million -7.7%N/A1.9 $8.01 12/15/202120,040,000 shares $163.73 million +3.7%N/A2.1 $8.17 11/30/202119,330,000 shares $159.47 million -1.3%N/A2 $8.25 11/15/202119,590,000 shares $184.93 million +1.8%N/A2.3 $9.44 10/29/202119,240,000 shares $168.16 million +9.4%N/A2.3 $8.74 10/15/202117,590,000 shares $170.27 million -10.3%N/A2.2 $9.68 9/30/202119,600,000 shares $190.90 million -11.8%N/A2.3 $9.74 9/15/202122,230,000 shares $199.40 million -4.6%N/A2.6 $8.97 8/31/202123,290,000 shares $219.39 million -18.4%N/A2.7 $9.42 8/13/202128,530,000 shares $280.45 million -14.2%N/A3.2 $9.83 7/30/202133,240,000 shares $320.77 million -2.0%N/A3.7 $9.65 7/15/202133,910,000 shares $297.39 million -1.1%N/A3.9 $8.77 6/30/202134,290,000 shares $339.47 million -3.6%N/A4.2 $9.90 6/15/202135,570,000 shares $385.93 million +1.2%N/A4.8 $10.85 5/28/202135,160,000 shares $365.66 million -1.0%N/A4.4 $10.40 5/14/202135,500,000 shares $369.91 million -3.5%3.2%4.3 $10.42 4/30/202136,770,000 shares $391.23 million +23.3%3.3%3.9 $10.64 4/15/202129,830,000 shares $324.55 million +19.1%2.7%3.3 $10.88 3/31/202125,040,000 shares $283.70 million -31.2%2.3%2.7 $11.33 3/15/202136,370,000 shares $392.43 million +13.2%3.3%3.6 $10.79Combine the QQQ, IWM and SPY in one trade (Ad)If you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here. 2/26/202132,140,000 shares $353.54 million -6.8%2.9%3.3 $11.00 2/12/202134,470,000 shares $389.51 million +12.6%3.1%3.7 $11.30 1/29/202130,620,000 shares $375.10 million +2.9%2.8%3.4 $12.25 1/15/202129,750,000 shares $342.13 million No Change2.7%3.3 $11.50 1/15/202057,090,000 shares $601.73 million -0.6%N/A3.2 $10.54 12/31/201957,460,000 shares $563.11 million -14.7%N/A3 $9.80 TEVA Short Interest - Frequently Asked Questions What is Teva Pharmaceutical Industries' current short interest? Short interest is the volume of Teva Pharmaceutical Industries shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 22,410,000 shares of TEVA short. Learn More on Teva Pharmaceutical Industries' current short interest. What is a good short interest ratio for Teva Pharmaceutical Industries? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TEVA shares currently have a short interest ratio of 3.0. Learn More on Teva Pharmaceutical Industries's short interest ratio. Which institutional investors are shorting Teva Pharmaceutical Industries? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Teva Pharmaceutical Industries: Jane Street Group LLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Verition Fund Management LLC, Walleye Trading LLC, Walleye Capital LLC, Crawford Fund Management LLC, Citigroup Inc., Wolverine Asset Management LLC, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Teva Pharmaceutical Industries' short interest increasing or decreasing? Teva Pharmaceutical Industries saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 22,410,000 shares, an increase of 5.8% from the previous total of 21,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Teva Pharmaceutical Industries' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Teva Pharmaceutical Industries: GSK plc (0.95%), Takeda Pharmaceutical Company Limited (0.15%), BioNTech SE (0.99%), BeiGene, Ltd. (1.37%), Moderna, Inc. (11.90%), Viatris Inc. (1.78%), Summit Therapeutics Inc. (2.28%), Genmab A/S (0.32%), Dr. Reddy's Laboratories Limited (1.32%), Sarepta Therapeutics, Inc. (6.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Teva Pharmaceutical Industries stock? Short selling TEVA is an investing strategy that aims to generate trading profit from Teva Pharmaceutical Industries as its price is falling. TEVA shares are trading up $4.37 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Teva Pharmaceutical Industries? A short squeeze for Teva Pharmaceutical Industries occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TEVA, which in turn drives the price of the stock up even further. How often is Teva Pharmaceutical Industries' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TEVA, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies GSK Short Squeeze TAK Short Squeeze BNTX Short Squeeze BGNE Short Squeeze MRNA Short Squeeze VTRS Short Squeeze SMMT Short Squeeze GMAB Short Squeeze RDY Short Squeeze SRPT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:TEVA) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TEVA Stock Alerts